Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIO-BRÆNDSEL DANMARK A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 4.2% 4.2%   Bankruptcy risk   2.8% 4.3% 2.8% 1.1% 3.0% 5.2% 9.6% 9.4%   Credit score (0-100)   61 49 58 82 57 42 26 26   Credit rating   BBB BBB BBB A BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 147.9 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,704 2,498 2,128 2,667 8,550 2,286 0.0 0.0   EBITDA   651 472 525 1,100 6,271 692 0.0 0.0   EBIT   551 403 456 1,031 6,222 692 0.0 0.0   Pre-tax profit (PTP)   364.3 172.2 266.4 896.2 5,971.0 618.2 0.0 0.0   Net earnings   282.8 132.8 207.5 676.6 4,656.2 477.2 0.0 0.0   Pre-tax profit without non-rec. items   364 172 266 896 5,971 618 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   256 187 118 48.8 0.0 0.0 0.0 0.0   Shareholders equity total   3,085 2,968 3,025 3,524 7,980 3,957 3,207 3,207   Interest-bearing liabilities   3,344 7,050 6,035 2,935 2,079 508 0.0 0.0   Balance sheet total (assets)   10,333 15,703 10,782 7,662 22,410 10,959 3,207 3,207   Net Debt   3,200 6,977 5,828 2,729 -2,166 -202 -3,207 -3,207     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,704 2,498 2,128 2,667 8,550 2,286 0.0 0.0   Gross profit growth   20.3% -7.6% -14.8% 25.3% 220.6% -73.3% -100.0% 0.0%   Employees   4 4 4 3 4 4 0 0   Employee growth %   0.0% 0.0% 0.0% -25.0% 33.3% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   10,333 15,703 10,782 7,662 22,410 10,959 3,207 3,207   Balance sheet change%   -6.7% 52.0% -31.3% -28.9% 192.5% -51.1% -70.7% 0.0%   Added value   650.7 472.4 524.9 1,100.0 6,291.4 691.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -4 -138 -138 -138 -98 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   20.4% 16.2% 21.4% 38.7% 72.8% 30.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   5.6% 3.4% 3.6% 11.4% 41.4% 5.0% 0.0% 0.0%   ROI %   9.6% 5.4% 5.0% 13.5% 75.3% 11.5% 0.0% 0.0%   ROE %   9.1% 4.4% 6.9% 20.7% 80.9% 8.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   29.9% 18.9% 28.1% 46.0% 35.6% 36.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   491.8% 1,476.8% 1,110.3% 248.1% -34.5% -29.2% 0.0% 0.0%   Gearing %   108.4% 237.6% 199.5% 83.3% 26.1% 12.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.5% 5.2% 3.2% 3.4% 10.0% 16.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 0.2 0.2 0.5 0.5 0.4 0.0 0.0   Current Ratio   1.4 1.2 1.4 1.8 1.6 1.6 0.0 0.0   Cash and cash equivalent   144.4 73.3 207.6 206.2 4,244.9 710.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,829.2 2,781.0 2,907.5 3,475.1 7,980.1 3,957.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   163 118 131 367 1,573 173 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   163 118 131 367 1,568 173 0 0   EBIT / employee   138 101 114 344 1,556 173 0 0   Net earnings / employee   71 33 52 226 1,164 119 0 0